We are live on
!
Find out more
Handelsbanken Fonder Portfolio holdings
AUM
$35.1B
1-Year Est. Return
47.76%
This Fund
S&P 500
This Quarter
Est. Return
+9%
1 Year Est. Return
+47.76%
3 Year Est. Return
+137.96%
5 Year Est. Return
+170.36%
10 Year Est. Return
+934.7%
AUM
$4.32B
AUM Growth
+$398M
(+10%)
Cap. Flow
+$107M
Cap. Flow
% of AUM
2.48%
Top 10 Holdings %
Top 10 Hldgs %
25.46%
Holding
209
New
40
Increased
76
Reduced
46
Closed
8
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$27M |
| 2 |
Bank OZK
OZK
|
+$24.7M |
| 3 |
Pool Corp
POOL
|
+$20M |
| 4 |
Baidu
BIDU
|
+$12.5M |
| 5 |
OPLN
Openlane
OPLN
|
+$9.02M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Hormel Foods
HRL
|
+$27.3M |
| 2 |
NetEase
NTES
|
+$18.8M |
| 3 |
TWX
Time Warner Inc
TWX
|
+$14.1M |
| 4 |
Sensient Technologies
SXT
|
+$13.4M |
| 5 |
Pediatrix Medical
MD
|
+$12.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 19.32% |
| 2 | Financials | 14.45% |
| 3 | Technology | 14.25% |
| 4 | Healthcare | 13.92% |
| 5 | Communication Services | 12.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Neurocrine Biosciences
NBIX
$16.5B
| $9.07M | 0.21% |
148,000
| – | – |
|
102
IMAX
IMAX
$2.77B
| $9.06M | 0.21% |
400,000
+100,000
| +33% | +$2.06M |
|
|
MOMO
103
Hello Group
MOMO
$861M
| $8.78M | 0.2% |
280,000
+40,000
| +17% | +$1.59M |
|
104
TAL Education Group
TAL
$6.75B
| $8.77M | 0.2% |
260,000
-100,000
| -28% | -$2.82M |
|
105
Microchip Technology
MCHP
$44B
| $8.65M | 0.2% |
192,800
+40,000
| +26% | +$1.68M |
|
106
JD.com
JD
$43.1B
| $8.48M | 0.2% |
222,000
+12,000
| +6% | +$514K |
|
|
CPLA
107
DELISTED
Capella Education Company
CPLA
| $8.42M | 0.19% |
120,000
-16,000
| -12% | -$1.16M |
|
108
Wynn Resorts
WYNN
$10.8B
| $8.19M | 0.19% |
55,000
-28,000
| -34% | -$3.82M |
|
|
SINA
109
DELISTED
Sina Corp
SINA
| $8.08M | 0.19% |
+70,500
| New | +$7.12M |
|
110
Exelixis
EXEL
$12.7B
| $7.97M | 0.18% |
329,000
-20,000
| -6% | -$532K |
|
111
MasTec
MTZ
$21.9B
| $7.89M | 0.18% |
+170,000
| New | +$7.4M |
|
112
Aptiv
APTV
$10.3B
| $7.87M | 0.18% |
80,000
| – | – |
|
113
Las Vegas Sands
LVS
$29.6B
| $7.83M | 0.18% |
122,000
-30,000
| -20% | -$1.86M |
|
|
EXAS
114
DELISTED
Exact Sciences
EXAS
| $7.68M | 0.18% |
163,000
-7,000
| -4% | -$282K |
|
|
EA
115
DELISTED
Electronic Arts
EA
| $7.67M | 0.18% |
65,000
+10,000
| +18% | +$1.16M |
|
116
Cinemark Holdings
CNK
$4.25B
| $7.24M | 0.17% |
200,000
-80,000
| -29% | -$2.9M |
|
117
Acadia Pharmaceuticals
ACAD
$5.07B
| $7.16M | 0.17% |
190,000
+13,000
| +7% | +$423K |
|
118
iShares MSCI Brazil ETF
EWZ
$8.6B
| $7.05M | 0.16% |
+169,000
| New | +$6.61M |
|
|
ARRY
119
DELISTED
Array Biopharma Inc
ARRY
| $6.99M | 0.16% |
568,000
+88,000
| +18% | +$817K |
|
120
Bristol-Myers Squibb
BMY
$130B
| $6.92M | 0.16% |
108,560
+23,000
| +27% | +$1.34M |
|
|
ALXN
121
DELISTED
Alexion Pharmaceuticals
ALXN
| $6.65M | 0.15% |
47,400
+3,000
| +7% | +$408K |
|
|
PFPT
122
DELISTED
Proofpoint, Inc.
PFPT
| $6.54M | 0.15% |
75,000
-10,000
| -12% | -$889K |
|
123
Baxter International
BAX
$14.3B
| $6.53M | 0.15% |
104,000
| – | – |
|
124
Itaú Unibanco
ITUB
$82.7B
| $6.51M | 0.15% |
979,502
| – | – |
|
125
Agios Pharmaceuticals
AGIO
$1.95B
| $6.51M | 0.15% |
97,500
-5,000
| -5% | -$300K |
|
Similar funds
VIA
Handelsbanken Fonder's Q3 2017 Portfolio in Review
As of Q3 2017, Handelsbanken Fonder held 209 positions worth $4.32B, up 10% from $3.92B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Handelsbanken Fonder's Q3 2017 filing shows 40 new, 76 increased, 46 reduced and 8 closed positions. Its largest new stake was Openlane: 546,894 shares worth $9.88M. The largest sale was Hormel Foods, an estimated $27.3M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 19% of assets, up from 19% a quarter earlier, followed by Financials and Technology.
- Handelsbanken Fonder's largest Q3 2017 buy was Openlane: 546,894 shares worth $9.88M.
- Handelsbanken Fonder added most to Alibaba in Q3 2017, an estimated $27M increase.
- Handelsbanken Fonder's biggest Q3 2017 reduction was NetEase, cutting an estimated $18.8M.
- Handelsbanken Fonder fully exited Hormel Foods in Q3 2017, selling an estimated $27.3M.
- Handelsbanken Fonder's ten largest holdings make up 25% of its $4.32B portfolio in Q3 2017.
- Handelsbanken Fonder opened 40 new positions and closed 8 in Q3 2017.
- Handelsbanken Fonder's portfolio value rose 10% quarter-over-quarter to $4.32B.
Based on Handelsbanken Fonder's 13F filing for Q3 2017, filed 24 Oct 2017.